Ramesh Rajpurohit
19Patents
8h-index
11Co-inventors
61Inventor score
Filing activity: Aug 8, 2003 → Jun 2, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7176279B2 | Cyclic peptide compositions and methods for treatment of sexual dysfunction | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7342089B2 | Cyclic peptides for treatment for cachexia | Emerging Cross-Sectional Technologies | 17 | Expired |
| US7326707B2 | Bicyclic melanocortin-specific compounds | Physics | 14 | Expired |
| US7354923B2 | Piperazine melanocortin-specific compounds | Human Necessities | 14 | Expired |
| US7456184B2 | Melanocortin receptor-specific compounds | Chemistry; Metallurgy | 14 | Expired |
| US7345144B2 | Cyclic peptides for treatment of cachexia | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7417027B2 | Linear and cyclic melanocortin receptor-specific peptides | Human Necessities | 12 | Expired |
| US7396814B2 | Metallopeptide compositions for treatment of sexual dysfunction | Human Necessities | 11 | Expired |
| US7807678B2 | Peptidomimetics of biologically active metallopeptides | Physics | 6 | Active |
| US7189755B2 | Pyrrolidine melanocortin-specific compounds | Physics | 5 | Expired |
| US7709484B1 | Substituted melanocortin receptor-specific piperazine compounds | Chemistry; Metallurgy | 4 | Active |
| US7964601B2 | Melanocortin receptor-specific compounds | Chemistry; Metallurgy | 4 | Active |
| US7795378B2 | Peptide compositions for treatment of sexual dysfunction | Human Necessities | 4 | Active |
| US8247530B2 | N-alkylated cyclic peptide melanocortin agonists | Human Necessities | 4 | Active |
| US7732451B2 | Naphthalene-containing melanocortin receptor-specific small molecule | Human Necessities | 3 | Active |
| US7718802B2 | Substituted melanocortin receptor-specific piperazine compounds | Chemistry; Metallurgy | 3 | Active |
| US7385025B2 | Metallopeptide compounds | Chemistry; Metallurgy | 0 | Expired |
| US7351690B2 | Knockout identification of target-specific sites in peptides | Physics | 0 | Expired |
| US7601753B2 | Pyrrolidine melanocortin-specific compounds | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.